Quick Answer
Iterum Therapeutics plc reported Total Assets of $44.59 million for fiscal year 2024.
Iterum Therapeutics plc Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2024 | $44.59M | +69.8% |
| 2023 | $26.26M | -60.7% |
| 2022 | $66.83M | -27.0% |
| 2021 | $91.51M | +179.1% |
| 2020 | $32.79M | +27.3% |
| 2019 | $25.75M | -73.7% |
| 2018 | $97.87M | +109.3% |
| 2017 | $46.76M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $32.50M | +104.1% | -4.4% |
| June 30, 2025 | $34.01M | +140.0% | +3.2% |
| March 31, 2025 | $32.98M | +68.0% | -26.1% |
| December 31, 2024 | $44.59M | +69.8% | +180.0% |
| September 30, 2024 | $15.92M | -59.9% | +12.3% |
| June 30, 2024 | $14.17M | -72.2% | -27.8% |
| March 31, 2024 | $19.62M | -66.2% | -25.3% |
| December 31, 2023 | $26.26M | -60.7% | -33.9% |
- Iterum Therapeutics plc showed an increase of +69.8% in Total Assets compared to the prior fiscal year.
- Over the 2017–2024 period, Iterum Therapeutics plc’s total assets has declined by 4.6% (from $46.76 million to $44.59 million).
- The most recent figure is from Iterum Therapeutics plc’s fiscal year 2024 report (Form 10-K), filed with the SEC on February 7, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: